Tenax Therapeutics Ratios (2010-2017) | TENX

Ratios Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Apr2014 Apr2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017
Profitability
Gross Margin -423.71%530.84%100.00%100.00%100.00%17.78%1.46%5.57%2.04%1.06%0.60%12.62%
EBT Margin -250,580.02%40,143.91%10,522.58%6,427.01%-11,513.99%-3,074.85%-4,866.90%-2,750.76%-1,323.56%-301.12%-1,085.17%-7,083.29%-2,801,840.35%
EBIT Margin -250,680.02%40,249.26%10,360.51%6,152.14%-9,761.90%-2,158.73%-1,263.83%-1,952.22%-615.75%-132.62%-715.64%-4,444.87%-2,801,940.35%
EBITDA Margin -250,680.02%40,249.26%10,360.51%6,152.14%-9,761.90%-2,158.73%-1,263.83%-1,952.22%-615.75%-132.62%-715.64%-4,444.87%-242,161.79%2,228,869.01%
Operating Margin -250,680.02%40,249.26%10,360.51%6,152.14%-9,761.90%-2,158.73%-1,263.83%-1,952.22%-615.75%-132.62%-715.64%-4,444.87%-2,801,940.35%
Net Margin -250,580.02%40,143.91%10,522.58%6,427.01%-11,513.99%-3,074.85%-4,866.90%-2,750.76%-1,323.56%-301.12%-1,085.17%7,081.99%2,246,578.63%
FCF Margin 209,329.10%-33,786.48%-9,737.26%-4,068.22%-8,257.17%-49,236.20%-35,501.41%-1,494.64%-597.44%-11,035.14%-25,881.82%-3,540.98%69,399.23%-206,043.07%
Efficiency
Inventory Average 0.23M0.15M0.11M0.10M0.10M0.11M0.11M0.10M
Assets Average 4.55M5.36M5.22M5.02M4.64M4.34M3.29M3.11M61.92M41.53M21.25M16.30M12.23M
Equity Average -2.67M-2.67M-2.30M-0.61M-0.49M-0.35M-0.83M-1.69M48.79M31.92M15.63M12.69M10.72M
Invested Capital -3.72M-1.62M-3.73M-0.87M-0.35M-0.64M-0.06M-1.60M-1.78M82.86M70.43M60.42M50.89M46.69M17.14M14.11M11.27M10.16M
Asset Utilization Ratio 0.020.040.060.070.130.240.340.860.05
Leverage & Solvency
Interest Coverage Ratio 0.00M382.08-63.93-22.38-5.57-2.36-0.35-2.44-0.87-0.79-1.94-1.680.03M
Debt to Equity -1.20-3.42-1.66-1.09-3.93-2.77-37.53-1.62-1.68
Debt Ratio 1.530.891.360.160.330.340.610.850.94
Equity Ratio -1.27-0.26-0.82-0.15-0.08-0.12-0.02-0.53-0.560.830.790.780.730.740.840.92
Times Interest Earned 0.00M382.08-63.93-22.38-5.57-2.36-0.35-2.44-0.87-0.79-1.94-1.680.03M
Valuation
Enterprise Value 61.27M48.45M47.37M40.51M53.86M50.04M69.20M49.73M30.52M32.76M21.93M6.08M-58.32M88.27M38.32M-3.26M62.06M57.64M41.57M3.30M12.06M1.65M
Market Capitalization 64.01M49.29M47.89M41.46M57.86M52.04M72.48M51.61M33.21M34.27M22.76M6.86M58.51M72.01M65.12M54.85M15.82M20.86M10.19M
Return Ratios
Return on Sales 143.26%47.91%-0.74%-32.48%-42.97%-26.79%-14.55%-9.22%-46.94%-29.97%
Return on Capital Employed 2.24%0.31%6.15%-4.35%-11.72%-2.04%-4.47%-64.89%-1.69%-1.83%
Return on Assets 1.06%-0.03%-1.95%-3.12%-3.53%-3.46%-3.10%-40.36%-2.27%-1.36%
Return on Equity -1.81%0.05%4.42%25.68%33.26%43.07%12.29%74.34%-2.88%-1.77%